| Product NDC: | 60505-0399 |
| Proprietary Name: | Diclofenac Sodium |
| Non Proprietary Name: | Diclofenac Sodium |
| Active Ingredient(s): | 16.05 mg/mL & nbsp; Diclofenac Sodium |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-0399 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202027 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121104 |
| Package NDC: | 60505-0399-5 |
| Package Description: | 1 BOTTLE in 1 CARTON (60505-0399-5) > 150 mL in 1 BOTTLE |
| NDC Code | 60505-0399-5 |
| Proprietary Name | Diclofenac Sodium |
| Package Description | 1 BOTTLE in 1 CARTON (60505-0399-5) > 150 mL in 1 BOTTLE |
| Product NDC | 60505-0399 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Diclofenac Sodium |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20121104 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | DICLOFENAC SODIUM |
| Strength Number | 16.05 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |